Over The Counter (OTC)

New OTC Nexium approved

The FDA has approved a 24-hour version of Pfizer's heartburn medication.

FDA seeks flexible OTC review process

The agency says is it time to update the onerous decades-old review process.

FDA panel to review NSAIDs this month

A panel is meeting February 10 to discuss revoking the OTC status of some medications.

Discontinued OTC asthma med may make comeback

An FDA committee is poised to review a new Primatene Mist in February.

J&J posts third-quarter progress

J&J posts third-quarter progress

By

The company beat consensus estimates, with particular sales strengths from its pharmaceuticals division.

Business briefs: Sanofi, Gilead, Eli Lilly, Boehringer, Girl Scouts

Sanofi pulls GLP-1 diabetes med from FDA review; Gilead files oncology drug; BI/Lilly reveals results of head-to-head trial of its SGLT2 inhibitor vs. Januvia; BI campaign animates heartburn market; Girl Scouts take on mental health

Valeant leverages Rx sales force, YouTube for OTC brand

Valeant leverages Rx sales force, YouTube for OTC brand

By

The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.

Business briefs: Sanofi, Celgene, plus changing cancer definitions

Sanofi may make OTC history; Celgene joins a new collaboration; and the US Task Force of Preventative Medicine wants to make lung cancer screening the norm

Business briefs: Teva, AbbVie, Novartis, Wockhardt

FDA grants Teva three years exclusivity to sell Plan B OTC for all ages; FDA gives Humira a thumbs-down for spondyloarthritis; a UK vaccine committee rejects Novartis' meningitis B shot; and Wockhardt gets a warning letter from FDA for its manufacturing practices at an Indian plant.

Not buying it: Medical professionals go generic, study shows

By

Researchers quantify the rate at which doctors, nurses and pharmacists buy off-label OTC drugs.

Merck's Heller on how to get more women into the C-suite

Merck's Heller on how to get more women into the C-suite

By

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.

For consumers, price isn't just a financial factor

By

A pair of studies suggests that consumers are hungry for information, and that price determines how patients perceive their risk for life-threatening conditions.

J&J OTC sales slipped 3% in 2012 worldwide

By

CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers.

Company news: Sanofi, Elsevier

Rolaids gets a French twist, and Elsevier packs the second week of the year with two news items.

Company news: Novo Nordisk

Novo Nordisk has launched a hemophilia app; and a report says the Chinese OTC market is going gangbusters

Excedrin relaunch features Sparks, "Thank yous" from migraine sufferers

Excedrin relaunch features Sparks, "Thank yous" from migraine sufferers

By

Novartis is hyping its relaunch of Excedrin with a celebrity spokesperson, a migraine app and a survey of women migraine sufferers - along with print and out-of-home ads, radio promotions, direct mail and social media.

Study: OTC ads are so over risk info

Study: OTC ads are so over risk info

By

A study of advertising for OTC switches found that presentation of risk information plummeted once the products advertised escaped the purview of the FDA.

Company news: GSK, Novartis and Boehringer Ingelheim

GlaxoSmithKline continues to shed businesses, but can't shake its weight-loss drug Alli (orlistat).

People news: Novartis, Qforma and Precision Health Media

Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.

As GSK jettisons consumer brands, smaller marketer sees boon

As GSK jettisons consumer brands, smaller marketer sees boon

By

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.

Bon Jovi enlists in Advil's battle with Tylenol

Bon Jovi enlists in Advil's battle with Tylenol

By

Jon Bon Jovi is the latest celebrity pitchman for Pfizer Consumer Healthcare's Advil.

Advil Congestion effort ties traffic gridlock to cold and flu misery

Advil Congestion effort ties traffic gridlock to cold and flu misery

By

Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.

OTC Lipitor? Good luck with that

OTC Lipitor? Good luck with that

By

Pfizer is reportedly weighing an attempt at an over-the-counter (OTC) switch for Lipitor - a move that could help the company recoup some of its losses when the $11 billion drug loses US exclusivity in November -- but the reception from analysts has been muted so far.

Desperate Housewives' Delany to flack Pfizer's Caltrate

Desperate Housewives' Delany to flack Pfizer's Caltrate

By

Desperate Housewives star Dana Delany will serve as the face of Pfizer's "Women Move the World" campaign for OTC supplement Caltrate. In a twist on the user-generated content formula, she'll invite women to submit their girl power-themed stories to the brand's Facebook page for consideration as advertising fodder

Ethnically insensitive Summer's Eve ads draw eyeballs and brickbats

Ethnically insensitive Summer's Eve ads draw eyeballs and brickbats

By

A feminine hygiene brand known for its boffo advertising is back with an anatomically-explicit ad campaign that's generating tons of publicity but also charges of racism.

GSW launches health and wellness practice

By

InVentiv's GSW is going after the consumer health and wellness market with an offshoot, dubbed The Well @GSW, aimed at OTC brands, consumer products and retail accounts.

Teva, P&G partner to form global OTC behemoth

By

Teva is partnering with Procter & Gamble in an OTC drug marketing joint venture that will boast annual sales of more than $1 billion -- and which could ultimately be worth four times that, the companies say.

With job stress high and money tight, women refocus on health, says survey

By

The percentage of women surveyed that said they're buying prescription medications was way up in 2010 - to 64% from 48% in 2009 - a jump the survey's sponsors, Saatchi & Saatchi Wellness and Time Inc.'s Health, said points to a recessionary refocusing on personal health with great potential for healthcare marketers.

GSK launches new Alli spots, hands five OTC brands to Meda

GSK launches new Alli spots, hands five OTC brands to Meda

By

GlaxoSmithKline launched new commercials for Alli, in time for New Year's resolutions and holiday overeating remorse, and handed off five OTC products to Meda Pharmaceuticals.

Pfizer hypes Advil line extension with TV ad, personal shopper offer

Pfizer hypes Advil line extension with TV ad, personal shopper offer

By

Pfizer Consumer Healthcare is launching an Advil line extension with a contest to win a personal shopper for "Black Friday," the Friday after Thanksgiving, when bargain-hunting holiday shoppers pack stores.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.